Lannett Company, Inc. (LCI) Stock: What Does the Chart Say Tuesday?

Tuesday, September 21, 2021 10:34 AM | InvestorsObserver Analysts

Mentioned in this article

Lannett Company, Inc. (LCI) Stock: What Does the Chart Say Tuesday?

Overall market sentiment has been down on Lannett Company, Inc. (LCI) stock lately. LCI receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Lannett Company, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on LCI!

See Full LCI Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With LCI Stock Today?

Lannett Company, Inc. (LCI) stock is trading at $2.95 as of 10:20 AM on Tuesday, Sep 21, a rise of $0.04, or 1.2% from the previous closing price of $2.92. The stock has traded between $2.90 and $2.97 so far today. Volume today is light. So far 77,979 shares have traded compared to average volume of 730,083 shares.

More About Lannett Company, Inc.

Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others. Click Here to get the full Stock Report for Lannett Company, Inc. stock.